Cite

HARVARD Citation

    Bracci, F. et al. (n.d.). Changing therapeutic strategy according to trough level of infliximab and antibodies in children affected by inflammatory bowel disease. Digestive and liver disease. pp. e265-e266. [Online]. 
  
Back to record